Diagnostic services provider Dr Lal PathLabs has announced its entry into the United Arab Emirates (UAE) with the incorporation of a wholly owned subsidiary in Dubai, marking a significant step in the company's international expansion strategy and strengthening its presence in the fast growing Middle
Session featured reflections from stalwarts, insights from current leaders, and aspirations of next-generation visionaries NEW DELHI, 8th October 2025: FICCI HEAL 2025, the 19th edition of FICCI’s annual healthcare conference supported by the Ministry of Health & Family Welfare and NITI Aayog, opened on October 8
In a pioneering move set to transform cancer diagnostics in India, Dr. Lal PathLabs (DLPL) has become the first laboratory in the country to adopt a deep learning-based AI module to detect lymph node metastasis, including micrometastasis, in cancer cases. This cutting-edge technology, validated in
Dr. Lal PathLabs Limited (“DLPL”), one of India’s most trusted diagnostic chains, has expanded its genomics capabilities by adding Illumina’s NovaSeq™ X Series to its dedicated genomics division, Genevolve. With the integration of Illumina’s latest technology, DLPL can now deliver faster and more accurate genomic
Dr. Lal PathLabs Limited (“DLPL” / “Dr. Lal PathLabs”), a leader in diagnostic healthcare, has introduced Amyloid Typing by Laser Capture Microdissection & Mass Spectrometry – a breakthrough test for accurately identifying different types of Amyloid proteins. With this launch, DLPL becomes the first diagnostic
FICCI-BDO India yesterday released ‘Expanding the Reach of Diagnostics: The Digital Advantage’ during the two-day ‘FICCI HEAL 2024’. The report explores the current state of the Indian diagnostic industry, emphasizing the transformative impact of digital innovations in addressing the challenges of access, affordability, and sustainability of diagnostic
Two-day ‘FICCI HEAL 2024’ concludes with strategic roadmap to strengthen primary healthcare, women’s health, medical education, and interdisciplinary learning in India The two-day ‘FICCI HEAL 2024’ culminated yesterday with deliberations aimed at transforming India’s healthcare landscape. Centred around the theme ‘Swasth Bharat, Viksit Bharat,’ the conference attracted healthcare
New leadership team announced at NATHEALTH Annual General Meeting 2024 Ms Ameera Shah, Promoter & MD, Metropolis Healthcare is Senior Vice President Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals Enterprises is Vice President Dr Om Manchanda, Managing Director, Dr Lal PathLabs is Treasurer Mr Anish Bafna, CEO &
A highly experienced & well known industry name, Mr Raj Sehgal, was last associated with Dr Lal PathLabs as Vice President of International Business and had previously been instrumental in leading Corporate Sales & North India Sales for them . He was also
